Status:

TERMINATED

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

Lead Sponsor:

SCRI Development Innovations, LLC

Collaborating Sponsors:

Aventis Pharmaceuticals

Pharmacia and Upjohn

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

Brief Summary

The epirubicin/docetaxel combination is one of the most active and best tolerated taxane/anthracycline combinations. In this phase II trial, we will further evaluate the feasibility, safety and effect...

Detailed Description

Upon determination of eligibility, all patients will receive: Docetaxel + Epirubicin Both drugs will be repeated at 21-day intervals

Eligibility Criteria

Inclusion

  • To be included in this study, you must meet the following criteria:
  • Metastatic breast cancer confirmed by biopsy.
  • Received no previous chemotherapy for metastatic breast cancer.
  • Prior hormonal therapy is acceptable.
  • Measurable or evaluable disease.
  • Able to perform activities of daily living without considerable assistance
  • Adequate bone marrow, liver and kidney function
  • Must be able to understand the nature of this study and give written informed consent.

Exclusion

  • You cannot participate in this study if any of the following apply to you:
  • Age \< 18 years.
  • Cardiac ejection fraction \< 45%.
  • Women who are pregnant or lactating.
  • Patients with meningeal metastases are ineligible.
  • Moderate peripheral neuropathy
  • History of hypersensitivity reaction to Taxotere
  • Males with metastatic breast cancer
  • Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have.

Key Trial Info

Start Date :

September 1 2001

Trial Type :

INTERVENTIONAL

End Date :

October 1 2004

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT00193024

Start Date

September 1 2001

End Date

October 1 2004

Last Update

May 3 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.